Skip to content

Virtual Reality in Motor Performance and Quality of Life in Patients With Parkinson's Disease

Virtual Reality in Motor Performance and Quality of Life in Patients With Parkinson's Disease

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01120392
Enrollment
40
Registered
2010-05-11
Start date
2011-05-31
Completion date
2011-10-31
Last updated
2011-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson's disease, Physical therapy, Virtual Reality, Quality of life, Motor performance

Brief summary

Treatment with Nintendo wii is higher to physical therapy conventional in the quality of life and motor performance in patients with Parkinson's disease.

Detailed description

The aim of this study is to assess if the treatment of rehabilitation with Nintendo wii is higher to the conventional in the quality of life and motor performance in patients with Parkinson's disease.

Interventions

OTHERtreatment with Nintendo wii.

Participants Will receive treatment with Nintendo Wii over one months. These Patients Will Be subjected to mobilization of stem and stretching. Then Will Be Submitted to Nintendo wii games. Will Be Submitted This group three times a week to a treatment protocol with boxing exercises with wii sports and wii fit

OTHERPhysical therapy conventional.

Conventional exercises used with the same goals for the group with wii

Sponsors

Federal University of Bahia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of Parkinson's disease * Both the sex with age between 50 and 80 years * To be in it I serve as apprentice of 1 the 3,0 in the scale of Hoehn Yahr

Exclusion criteria

* Cognitive impairment * Poorly controlled arterial hypertension * Poorly controlled Cardiopathy

Design outcomes

Primary

MeasureTime frameDescription
Quality of life4 weeks (Baseline and after four weeks)Parkinson's disease questionnaire (PDQ-39)
Motor performance4 weeks (Baseline and after four weeks)the Unified Parkinson's Disease Rating Scale (UPDRS.)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026